CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.
Dalerba P, Sahoo D, Paik S, Guo X, Yothers G, Song N, Wilcox-Fogel N, Forgó E, Rajendran PS, Miranda SP, Hisamori S, Hutchison J, Kalisky T, Qian D, Wolmark N, Fisher GA, van de Rijn M, Clarke MF.
Dalerba P, et al.
N Engl J Med. 2016 Jan 21;374(3):211-22. doi: 10.1056/NEJMoa1506597.
N Engl J Med. 2016.
PMID: 26789870
Free PMC article.